Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia

NCT03230864 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT03230864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Terminated
Start date
July 20, 2017
Completion date
February 5, 2019
Enrollment
119 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

treatment-resistant schizophrenia